Autologous Mononuclear cell therapy
Showing 1 - 25 of >10,000
Sequelae of Injuries of Head Trial in Hanoi (autologous bone marrow-derived mononuclear cell transplantation, Rehabilitation
Recruiting
- Sequelae of Injuries of Head
- autologous bone marrow-derived mononuclear cell transplantation
- Rehabilitation therapy
-
Hanoi, Vietnam
- +1 more
Mar 14, 2022
Chronic Limb-threatening Ischemia, Diabetes Trial in Bucaramanga (Cell-based therapy)
Completed
- Chronic Limb-threatening Ischemia
- Diabetes Mellitus
- Cell-based therapy
-
Bucaramanga, ColombiaFundación Oftalmológica de Santander (FOSCAL)
Nov 20, 2022
Sensorineural Hearing Loss Trial in Orlando (Autologous Bone Marrow Infusion)
Suspended
- Sensorineural Hearing Loss
- Autologous Bone Marrow Infusion
-
Orlando, FloridaFlorida Hospital for Children
Mar 16, 2022
Arterial Occlusive Diseases Trial in Frankfurt (intraarterial stem cell therapy, Stem cells)
Completed
- Arterial Occlusive Diseases
- intraarterial stem cell therapy
- Stem cells
-
Frankfurt, GermanyDiv. of Cardiology and Vascular Medicine
Oct 18, 2021
Malignant Tumor Trial in Los Angeles (biological, drug, other, radiation, procedure)
Active, not recruiting
- Malignant Neoplasm
- aldesleukin
- +7 more
-
Los Angeles, CaliforniaUniversity of California at Los Angeles (UCLA )
Dec 1, 2022
Stem Cell Infusion Trial in Hanoi (Autologous bone marrow mononuclear cell transplantation)
Completed
- Stem Cell Infusion
- Autologous bone marrow mononuclear cell transplantation
-
Hanoi, VietnamVinmec Research Institute of Stem Cell and Gene Technology
Jul 20, 2022
Chronic Atrophic Gastritis Trial in Jinan (Mononuclear cells, Weifuchun+Hydrotalcite/L-Glutamine and Sodium Gualenate Granules)
Not yet recruiting
- Chronic Atrophic Gastritis
- Mononuclear cells
- Weifuchun+Hydrotalcite/L-Glutamine and Sodium Gualenate Granules
-
Jinan, Shandong, ChinaShandong Provincial Hospital
Mar 29, 2023
Neonatal Necrotizing Enterocolitis, Growth and Development, Preterm Infants Trial in Guangzhou (Autologous Umbilical Cord Blood
Recruiting
- Neonatal Necrotizing Enterocolitis
- +3 more
- Autologous Umbilical Cord Blood Mononuclear Cells Therapy
- 0.9% Sodium Chloride
-
Guangzhou, Guangdong, ChinaJie Yang
Apr 22, 2022
Infertility Trial in Sofia (Intrauterine administration of PBMC immunomodulated with IFNt)
Recruiting
- Infertility
- Intrauterine administration of PBMC immunomodulated with IFNt
-
Sofia, BulgariaNadezhda Women's Health Hospital
Mar 7, 2023
ALS (Amyotrophic Lateral Sclerosis) Trial in Murcia (MNC (Mononuclear cells), Placebo / Saline)
Not yet recruiting
- ALS (Amyotrophic Lateral Sclerosis)
- MNC (Mononuclear cells)
- Placebo / Saline
-
Murcia, SpainHospital Clinico Universitario Virgen de la Arrixaca
Apr 15, 2021
Ischemic Stroke Trial in Cadiz, Córdoba, Seville (Autologous bone marrow mononuclear cell intra-arterial injection)
Active, not recruiting
- Ischemic Stroke
- Autologous bone marrow mononuclear cell intra-arterial injection
-
Cadiz, Spain
- +3 more
Feb 15, 2022
Neuroendocrine Tumor (NET), Colorectal Cancer (CRC) Trial (CHM-2101 CAR-T cells)
Not yet recruiting
- Neuroendocrine Tumor (NET)
- Colorectal Cancer (CRC)
- CHM-2101 CAR-T cells
- (no location specified)
Sep 20, 2023
Peripheral Blood Mononuclear Cells From Healthy People for
Recruiting
- Healthy Volunteer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 20, 2022
Hypoplastic Left Heart Syndrome, Heart Defects, Congenital, Pediatric Disorder Trial in Melbourne (Autologous Human Placental
Completed
- Hypoplastic Left Heart Syndrome
- +2 more
- Autologous Human Placental Cord Blood Mononuclear Cells
-
Melbourne, Victoria, AustraliaRoyal Children's Hospital
Jul 19, 2022
Complication Trial in Dongguan, Guangzhou (autologous cord blood mononuclear cells, normal saline)
Recruiting
- Complication
- autologous cord blood mononuclear cells
- normal saline
-
Dongguan, Guangdong, China
- +1 more
Oct 9, 2021
Hepatocellular Carcinoma Trial in Jakarta Pusat (Autologous Natural Killer Cell Therapy, Clinimacs Plus)
Recruiting
- Hepatocellular Carcinoma
- Autologous Natural Killer Cell Therapy
- Clinimacs Plus
-
Jakarta Pusat, Jakarta, IndonesiaCipto Mangunkusumo General Hospital
Sep 24, 2023
Brain Injuries, Traumatic, Brain Injuries, Acute, TBI (Traumatic Brain Injury) Trial in Houston (Placebo Infusion, Autologous
Enrolling by invitation
- Brain Injuries, Traumatic
- +2 more
- Placebo Infusion
- Autologous BMMNC Infusion
-
Houston, TexasThe University of Texas Health Science Center at Houston
Aug 1, 2022
ASCT Versus Chemotherapy as First-Line Consolidation Therapy
Completed
- T-cell Lymphoma Adults
- consolidation with ASCT
- (no location specified)
Nov 25, 2023
NK Cell, B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory Trial in Hubei (autologous NK cell)
Not yet recruiting
- NK Cell
- +2 more
- autologous NK cell
-
Hubei, Xiangyang, ChinaEC of Xiangyang No.1 People's Hospital Hubei University of Medic
Jun 19, 2023
Lymphomas, B-cell Lymphomas Trial in Houston (JV-213, Leukapheresis)
Not yet recruiting
- Lymphomas
- B-cell Lymphomas
- JV-213
- Leukapheresis
-
Houston, TexasThe University of Texas M D Anderson Cancer Center
Mar 6, 2023
Hematologic Malignancy, Large B-cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Los Angeles (autologous hematopoietic stem
Not yet recruiting
- Hematologic Malignancy
- +5 more
- autologous hematopoietic stem cells added to planned CAR T
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
May 31, 2023
Castration Resistant Prostate Cancer, CRPC Trial in Seoul (Cellgram-DC-PC)
Terminated
- Castration Resistant Prostate Cancer, CRPC
- Cellgram-DC-PC
-
Seoul, Korea, Republic ofAsan medical center
Dec 29, 2022
Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)
Not yet recruiting
- Multiple Myeloma
- Iberdomide
- Daratumumab/rHuPH20 Co-formulation
- (no location specified)
Oct 25, 2023
Autism Spectrum Disorder Trial in Hanoi (Autologous BMMNCs transplantation and educational intervention)
Recruiting
- Autism Spectrum Disorder
- Autologous BMMNCs transplantation and educational intervention
-
Hanoi, VietnamVinmec Research Institute of Stem Cell and Gene Technology
Mar 23, 2022
Ovarian Cancer Trial in Seoul (Cellgram-DC)
Terminated
- Ovarian Cancer
- Cellgram-DC
-
Seoul, Korea, Republic ofAsan medical center
Dec 29, 2022